Immediate Impact
15 from Science/Nature 63 standout
Citing Papers
Management of ALL in adults: 2024 ELN recommendations from a European expert panel
2024 Standout
Acute myeloid leukaemia
2023 Standout
Works of Pascal Turlure being referenced
Gemtuzumab ozogamicin for de novo acute myeloid leukemia: final efficacy and safety updates from the open-label, phase III ALFA-0701 trial
2018
High efficacy and safety profile of fractionated doses of Mylotarg as induction therapy in patients with relapsed acute myeloblastic leukemia: a prospective study of the alfa group
2006
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Pascal Turlure | 2026 | 927 | 645 | 1160 | 114 | 3.1k | |
| Frederick R. Davey | 2238 | 879 | 542 | 978 | 107 | 3.7k | |
| Giuliana Alimena | 3569 | 2066 | 658 | 1021 | 206 | 4.6k | |
| Dale L. Bixby | 1590 | 838 | 740 | 1112 | 134 | 3.1k | |
| Eric Wattel | 1971 | 1117 | 750 | 1386 | 131 | 4.4k | |
| F. G. J. Hayhoe | 1240 | 1023 | 531 | 941 | 111 | 3.5k | |
| Thoralf Lange | 2948 | 1380 | 942 | 472 | 113 | 3.9k | |
| Koichi Miyamura | 2228 | 643 | 724 | 520 | 203 | 3.6k | |
| Hideaki Mizoguchi | 1523 | 673 | 667 | 902 | 139 | 3.4k | |
| Jenny Byrne | 2104 | 831 | 1017 | 570 | 120 | 3.0k | |
| Zaher K. Otrock | 1099 | 370 | 541 | 750 | 115 | 2.9k |
All Works
Loading papers...